hematoporphyrin has been researched along with fluorouracil in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cowled, PA; Forbes, IJ; Mackenzie, L | 1 |
| Franke, HD | 1 |
| Ishikawa, M | 1 |
| Canti, G; Franco, P; Marelli, O; Nicolin, A; Ricci, L | 1 |
| Gerhardt, T; Heller, J; Höblinger, A; Rings, D; Sauerbruch, T; Schepke, M | 1 |
| He, H; Huang, P; Liu, Y; Yu, T; Zhang, Y; Zhou, S | 1 |
| Gu, Y; Huang, N; Liu, Q; Mao, Y; Qiu, H; Wang, Y; Yang, Y; Zeng, J; Zhu, J | 1 |
8 other study(ies) available for hematoporphyrin and fluorouracil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Synergism; Fluorouracil; Hematoporphyrin Derivative; Hematoporphyrins; Lung Neoplasms; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Phototherapy; Radiation Tolerance; Thiotepa; Vincristine | 1987 |
[Use of radiation sensitizing agents in radiotherapy].
Topics: Acetates; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Choline; Cysteine; Fluorouracil; Hematoporphyrins; Humans; Hydrogen Peroxide; Mitosis; Nitrogen Oxides; Oxygen; Periodicity; Quinones; Radiation-Sensitizing Agents; Radiotherapy; Steroids; Thyroid Hormones; Trypan Blue; Urethane; Uridine; Vitamins | 1972 |
[Effects of "cell membrane-acting" substances on uptake of anticancer chemotherapeutics by tumor cells--with special reference to mitomycin C uptake by Ehrlich ascites tumor cells in vitro--].
Topics: Animals; Antifungal Agents; Carcinoma, Ehrlich Tumor; Cell Membrane Permeability; DNA, Neoplasm; Fluorouracil; Hematoporphyrins; In Vitro Techniques; Male; Mice; Mitomycins; Porphyrins; Rats; Snakes; Venoms | 1969 |
Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
Topics: Animals; Antibody Formation; Antineoplastic Agents; Cyclophosphamide; Fluorouracil; Hemagglutination; Hematoporphyrin Derivative; Hematoporphyrins; Hemolysis; Leukemia L1210; Leukocytes; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred Strains; Radiotherapy | 1984 |
Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Camptothecin; Cholangiocarcinoma; Cholestasis, Intrahepatic; Combined Modality Therapy; Deoxycytidine; Duodenoscopy; Feasibility Studies; Female; Fluorouracil; Gemcitabine; Hematoporphyrins; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Stents; Treatment Outcome | 2010 |
Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Doxorubicin; Fluorouracil; Hematoporphyrins; Humans; Microbubbles; Mitomycin; Ultrasonic Therapy | 2011 |
The potential of photodynamic therapy to treat esophageal candidiasis coexisting with esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Endoscopy; Esophageal Neoplasms; Fluorouracil; Hematoporphyrins; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2014 |